⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Syringaresinol
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-01 — Syringaresinol Attenuates Aging-Associated Ferroptosis-Relevant Stress Through an HIF-1α-GPX4 Defense Axis.: C. elegans lifespan/healthspan extension plus DEM-challenge survival, and dose-dependent protection of primary human fibroblasts from RSL3/erastin ferroptosis with GPX4/SLC7A11/ferritin recovery via an HIF-1α axis; nematode + human cell preclinical only, no mammalian in vivo data. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Syringaresinol Attenuates Aging-Associated Ferroptosis-Relevant Stress Through an HIF-1α-GPX4 Defense Axis.
01-jul-2026
novelty 3
per-area 3
strengthens